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Abstract
Leading national organizations are increasingly using evidence-based recommendations for 
Papanicolaou testing. As of 2003, organizations recommended against Papanicolaou testing for 
women without a cervix following a hysterectomy who do not have a history of high-grade 
precancerous lesion or cervical cancer and for women older than 65 years with adequate prior 
screening and who are not at high risk.1–3 Few studies have investigated overuse of Papanicolaou 
testing among US women. We aimed to investigate overuse of Papanicolaou testing in relation to 
cervical cancer screening recommendations.
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A cross-sectional study was conducted using data from the 2010 National Health Interview 
Survey (NHIS). The NHIS is a nationally representative survey of the civilian non-
institutionalized population of the United States that uses a random, stratified, multistage 
cluster sampling design. Analyses of public use data are considered exempt by the 
institutional review board (IRB) of the National Cancer Institute; IRB approval and 
informed consent were obtained in the original study. In 2010, the NHIS included a Cancer 
Control Supplement, which is the most recently available national data set that includes 
detailed items on cervical cancer screening and hysterectomy status, including, for the first 
time, questions to assess date of self-reported hysterectomy. The Cancer Control 
Supplement, fielded to adults 18 years and older, had a response rate of 60.8%.4 Because 
women younger than 30 years are less likely to have undergone a hysterectomy, our study 
sample includes women 30 years and older from NHIS 2010 who responded to questions 
about Papanicolaou test use and hysterectomy status and reported that their Papanicolaou 
test was for screening purposes (“part of a routine exam”) (N = 9494).
We examined sociodemographic characteristics for our study sample by hysterectomy status 
and age. We then investigated timing of most recent Papanicolaou test (within the past year, 
1–3 years ago, >3 years ago) by sociodemographic characteristics and by hysterectomy 
status. National estimates of Papanicolaou testing overuse were calculated using the 
population weights from the 2010 NHIS. Women who reported a history of cervical cancer, 
an abnormal Papanicolaou test result within the past 3 years, or whose last Papanicolaou test 
was not part of a routine test were excluded from the results used to generate the national 
estimates. SAS-callable SUDAAN, version 9.2, was used in all analyses to account for the 
stratification and clustering of data within the complex survey design of the NHIS.
Results
Among women reporting a hysterectomy, 34.1%(95% CI, 31.7%–36.6%) reported a 
Papanicolau test in the past year (Table 1).A total of 64.8%(95% CI, 62.2%–67.3%) of 
women reporting a hysterectomy also reported a recent Papanicolaou test since their 
hysterectomy, and among women 65 years and older without a hysterectomy, 58.4% (95% 
CI, 55.3%–61.4%) reported receipt of a Papanicolaou test in the past 3 years (Table 2), 
together representing approximately 14 million women.
Discussion
For more than a decade, the US Preventive Services Task Force (USPSTF) has 
recommended that women discontinue Papanicolaou testing if they have received a total 
hysterectomy and have no history of cervical cancer or if they are older than 65 years and 
have ongoing and recent normal Papanicolaou test results.5 Nevertheless, in 2010, nearly 
two-thirds of women reported a Papanicolaou test since their hysterectomy and 
approximately one-half of women older than 65 years reported a Papanicolaou test in the 
past 3 years. With the implementation of the Affordable Care Act, the use of electronic 
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medical records, health care provider reminder systems, decision support, and new strategies 
to improve quality of care may improve guideline-consistent practices among clinicians.6
Limitations of this study are the use of self-reported data to obtain information on 
Papanicolaou testing and the lack of detail on type of hysterectomy received and on whether 
older women were adequately screened prior to stopping use of the test.
Misuse of Papanicolaou testing continues despite USPSTF recommendations, and health 
care resources could be spent better elsewhere. Targeted efforts are needed to reduce 
unnecessary testing among older women and women without a cervix in compliance with 
clinical recommendations for cervical cancer prevention.
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Table 2
Receipt of a Papanicolaou Test Among Women 30 Years and Older by Hysterectomy Status and 
Sociodemographic Characteristics, National Health Interview Survey (NHIS) (2010)a
Characteristic
Women Who Received a Papanicolaou Test Within the Past 3 Years, No. (% [95% CI])
Reporting Hysterectomyb Reporting No Hysterectomy
Total 1705 (64.8 [62.2–67.3]) 7160 (80.7 [79.6–81.8])
Age, y
  30–44 97 (87.8 [79.5–93.1]) 2738 (87.8 [86.1–89.3])
  45–64 836 (73.3 [69.8–76.6]) 2947 (83.8 [82.0–85.4])
  ≥65 772 (50.8 [46.5–55.0]) 1475 (58.4 [55.3–61.4])
Race/ethnicity
  Non-Hispanic white 1126 (61.5 [58.4–64.4]) 4179 (79.7 [78.2–81.1])
  Non-Hispanic black 337 (76.3 [70.3–81.3]) 1140 (82.2 [79.6–84.5])
  Hispanic or Latino 190 (74.2 [66.9–80.3]) 1337 (83.0 [80.3–85.4])
  Other 52 (70.9 [54.4–83.3]) 504 (85.4 [81.5–88.6])
Education
  Less than high school 318 (56.2 [49.4–62.7]) 1107 (66.7 [63.0–70.2])
  High school graduate or GED 570 (64.1 [59.3–68.6]) 1764 (73.0 [70.7–75.3])
  Some college 523 (69.6 [65.0–73.8]) 2090 (83.0 [81.0–84.8])
  College graduate or greater 291 (66.1 [59.3–72.2]) 2184 (89.3 [87.8–90.7])
  Missing 3 15
Proportion of poverty level, %
  <200 832 (57.6 [53.2–61.8]) 3194 (71.5 [69.6–73.3])
  200 to <400 368 (61.0 [55.4–66.4]) 1456 (79.7 [77.3–81.9])
  ≥400 505 (75.5 [71.4–79.2]) 2508 (89.3 [87.8–90.7])
  Missing 0 2
Health care coveragec
  Private only 334 (80.3 [74.7–84.9]) 1996 (88.6 [86.9–90.1])
  Public only 514 (52.9 [47.7–58.1]) 1469 (69.3 [66.2–72.3])
  Public and private 710 (63.9 [59.7–67.8]) 2617 (85.0 [83.4–86.5])
  None 144 (62.5 [52.1–71.9]) 1064 (64.2 [60.8–67.5])
  Missing 3 14
Has a usual source of health care
  Yes 1625 (65.4 [62.7–67.9]) 6379 (82.6 [81.5–83.7])
  No 80 (50.8 [36.5–65.0]) 781 (63.2 [58.8–67.4])
Abbreviation: GED, General Education Development.
a
All women 30 years and older, excluding women who report history of cervical cancer or an abnormal Papanicolaou test result in the past 3 years 
and women whose last Papanicolaou test was not a routine test. Percentages are weighted estimates. Missing responses are not included in the 
denominator. All analyses account for the stratification and clustering of data within the complex survey design of the NHIS.
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b
Among women who reported a hysterectomy more than 3 years ago. Cases in which it could not be determined whether the hysterectomy or the 
Papanicolaou test came first were excluded.
c
Private insurance includes military insurance; public insurance includes Medicaid, Medicare, State Children’s Health Insurance Program (SCHIP), 
Indian Health Service (IHS), other public, and other government insurance types; single service plan is considered underinsured and is included 
with uninsured.
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